Cytokinetics
CYTK
99 hedge funds and large institutions have $140M invested in Cytokinetics in 2015 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 44 increasing their positions, 27 reducing their positions, and 10 closing their positions.
63% more repeat investments, than reductions
Existing positions increased: 44 | Existing positions reduced: 27
50% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 10
5% more funds holding
Funds holding: 94 → 99 (+5)
9% more call options, than puts
Call options by funds: $2.41M | Put options by funds: $2.21M
5% more capital invested
Capital invested by funds: $133M → $140M (+$6.59M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TC
TFS Capital
West Chester,
Pennsylvania
|
+$4.72M |
| 2 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$2.77M |
| 3 |
Millennium Management
New York
|
+$1.18M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$681K |
| 5 |
NI
Numeric Investors
Boston,
Massachusetts
|
+$632K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IIM
Ironwood Investment Management
Boston,
Massachusetts
|
-$1.15M |
| 2 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$1.13M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$1.06M |
| 4 |
D.E. Shaw & Co
New York
|
-$899K |
| 5 |
HCM
Highbridge Capital Management
New York
|
-$746K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
HCM
101
Highbridge Capital Management
New York
| – | -$746K | -110,169 | Closed |
|
|
PA
102
Perceptive Advisors
New York
| – | -$205K | -30,227 | Closed |
|
|
ARTA
103
A.R.T. Advisors
New York
| – | -$196K | -29,045 | Closed |
|
|
PAM
104
Princeton Alpha Management
Princeton Junction,
New Jersey
| – | -$136K | -19,994 | Closed |
|
|
VKH
105
Virtu KCG Holdings
New York
| – | -$117K | -17,198 | Closed |
|
|
GMIM
106
General Motors Investment Management
New York
| – | -$117K | -17,184 | Closed |
|
107
Commonwealth Equity Services
Waltham,
Massachusetts
| – | -$102K | -15,092 | Closed |
|
|
QI
108
Quotient Investors
New York
| – | -$100K | -14,800 | Closed |
|
|
TRCT
109
Tower Research Capital (TRC)
New York
| – | -$30K | -4,437 | Closed |
|
CYTK Hedge Fund Activity: Q2 2015 in Review
99 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Cytokinetics (CYTK) for Q2 2015, worth a combined $140M — up 4.9% from $133M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new CYTK positions and 10 closed out — a net gain of 5 holders — while 44 added to existing stakes and 27 trimmed.
The largest buyer was TFS Capital, adding an estimated $4.72M. The largest seller was Ironwood Investment Management, cutting an estimated $1.15M.
- 99 institutional investors held Cytokinetics (CYTK) as of Q2 2015, up from 94 in Q1 2015.
- Funds reported $140M of Cytokinetics stock for Q2 2015, up 4.9% quarter-over-quarter.
- 15 funds opened new Cytokinetics positions in Q2 2015 and 10 closed out, a net change of +5 holders.
- The largest Cytokinetics buyer in Q2 2015 was TFS Capital, an estimated $4.72M added.
- The largest Cytokinetics seller in Q2 2015 was Ironwood Investment Management, an estimated $1.15M sold.
Based on aggregated 13F filings for Q2 2015.